Erratum to: Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy

Erratum to: Osteoporos Int

DOI 10.1007/s00198-013-2332-7

The legends for Figs. 2 and 3 appeared in the correct places but were accompanied by the wrong illustrations: Fig. 2 legend by Fig. 3 illustrations, and Fig. 3 legend by Fig. 2 illustrations. The two figures are reproduced here in their correct form.

Fig. 2

Hip fracture rate. 95 % confidence intervals around point estimate. Note the early separation of the two cohorts with a lower fracture rate for risedronate than for alendronate during the early phase (6–12 months) of treatment

Fig. 3

Nonvertebral fracture rate. 95 % confidence intervals around point estimate. Note the early separation of the two cohorts with a lower fracture rate for risedronate than for alendronate during the early phase (6–12 months) of treatment